Sensex, Nifty close flat amid volatile session; CG Power locks in at upper circuit, Deepak Nitrite tumbles by five per cent
Sensex, Nifty close flat amid volatile session; CG Power locks in at upper circuit, Deepak Nitrite tumbles by five per cent

Sensex, Nifty close flat amid volatile session; CG Power locks in at upper circuit, Deepak Nitrite tumbles by five per cent

DSIJ Intelligence Article rating: 4.2

Ending the week, domestic benchmark indices closed flat with a positive bias on Friday, as Sensex gained by a mere 0.04 per cent or 15.12 points to settle at 38,040.57 while Nifty rose by 0.12 per cent or by 13.90 points to reach the level of 11,214.05.

Prince Pipes rises 11.74 per cent on technical collaboration with Tooling Holland
Prince Pipes rises 11.74 per cent on technical collaboration with Tooling Holland

Prince Pipes rises 11.74 per cent on technical collaboration with Tooling Holland

DSIJ Intelligence Article rating: 3.4

Prince Pipes and Fittings Limited (PPFL), one of India’s largest integrated piping solutions & multi polymer manufacturers, announced that the company has entered into a technical collaboration with Tooling Holland BV, a global leader in the international plastic injection moulding industry based in the Netherlands.

Top performing pharma funds
Top performing pharma funds

Top performing pharma funds

DSIJ Intelligence Article rating: 3.8

Lately, pharma funds have performed spectacularly giving double-digit returns. Here are the top pharma funds that you can consider investing in.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 4.1

The market opened in red on August 7, 2020, overall volumes in futures & options currently stand at 6,09,80,826 crore contracts with a turnover of Rs. 39,88,372.83 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 3.2

The market opened in red on August 7, 2020, overall volumes in futures & options currently stand at 6,09,80,826 crore contracts with a turnover of Rs. 39,88,372.83 crore.

Glenmark to launch higher strength version of oral antiviral FabiFlu
Glenmark to launch higher strength version of oral antiviral FabiFlu

Glenmark to launch higher strength version of oral antiviral FabiFlu

DSIJ Intelligence Article rating: 4.8

Global pharma major, Glenmark Pharmaceuticals announced on Thursday that it is launching a 400 mg version of oral antiviral FabiFlu, for the treatment of mild to moderate COVID-19 in India. Glenmark Pharmaceuticals was the first company in the country to have received the regulator’s approval for 400 mg dosage form.

RSS
First29132914291529162918292029212922Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR